Puma Biotechnology Inc - Common Stock (NQ:PBYI)
Price and Volume
Detailed Quote| Volume | 172,089 |
| Open | 6.990 |
| Bid (Size) | 6.000 (100) |
| Ask (Size) | 7.410 (100) |
| Prev. Close | 7.010 |
| Today's Range | 6.920 - 7.080 |
| 52wk Range | 3.030 - 7.898 |
| Shares Outstanding | 47,509,765 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Puma Biotechnology Q1 Earnings Call Highlights ↗
May 08, 2026
Earnings Scheduled For November 6, 2025 ↗
November 06, 2025
Puma Biotech (PBYI) Earnings Call Transcript ↗
February 26, 2026
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
December 22, 2025
12 Health Care Stocks Moving In Monday's Intraday Session ↗
November 10, 2025
Puma Biotechnology Reports Third Quarter 2025 Financial Results
November 06, 2025
Frequently Asked Questions
Is Puma Biotechnology Inc - Common Stock publicly traded?
Yes, Puma Biotechnology Inc - Common Stock is publicly traded.
What exchange does Puma Biotechnology Inc - Common Stock trade on?
Puma Biotechnology Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Puma Biotechnology Inc - Common Stock?
The ticker symbol for Puma Biotechnology Inc - Common Stock is PBYI on the Nasdaq Stock Market
What is the current price of Puma Biotechnology Inc - Common Stock?
The current price of Puma Biotechnology Inc - Common Stock is 7.030
When was Puma Biotechnology Inc - Common Stock last traded?
The last trade of Puma Biotechnology Inc - Common Stock was at 06/05/26 04:00 PM ET
What is the market capitalization of Puma Biotechnology Inc - Common Stock?
The market capitalization of Puma Biotechnology Inc - Common Stock is 333.99M
How many shares of Puma Biotechnology Inc - Common Stock are outstanding?
Puma Biotechnology Inc - Common Stock has 334M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube